Review Measurement Properties of the Patient Health Questionnaire–15 and Somatic Symptom Scale–8: A Systematic Review and Meta-Analysis 2024 Axelsson et al

Key Points

Question What is known about the measurement properties of the Patient Health Questionnaire–15 (PHQ-15) and Somatic Symptom Scale–8 (SSS-8)?

Findings This systematic review and meta-analysis of 305 studies with 361 243 participants found that general and symptom domain–specific factors contributed to response patterns. The PHQ-15 (α = 0.81) and SSS-8 (α = 0.80) exhibited adequate internal consistency, but with redundant PHQ-15 items. Correlations with other scales generally supported construct validity; a difference of 3 or greater constituted a relevant change on both scales; and screening properties for the identification of somatoform disorders were suboptimal.

Meaning The findings of this study suggest that the PHQ-15 and SSS-8 can be recommended for assessment and monitoring of somatic symptom burden, but clinicians need to be aware that such scores reflect complex, multifactorial structures.

Abstract

Importance The subjective experience of somatic symptoms is a key concern throughout the health care system. Valid and clinically useful instruments are needed.

Objective To evaluate the measurement properties of 2 widespread patient-reported outcomes: the Patient Health Questionnaire–15 (PHQ-15) and Somatic Symptom Scale–8 (SSS-8).

Data Sources Medline, PsycINFO, and Web of Science were last searched February 1, 2024.

Study Selection English-language studies reporting estimates pertaining to factor analysis, taxometric analysis, internal consistency, construct validity, mean scores in relevant groups, cutoffs, areas under the receiver operating characteristic curves (AUROCs), minimal clinically important difference, test-retest reliability, or sensitivity to change.

Data Extraction and Synthesis Search hits were reviewed by independent raters. Cronbach α, Pearson r, means, and between-group effect sizes indicative of sensitivity to change were pooled in random-effects meta-analysis. Study quality was assessed using 3 instruments. Reporting followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses 2020 reporting guideline.

Main Outcomes and Measures Comprehensive overview of evidence pertaining to the measurement properties of the PHQ-15 and SSS-8.

Results A total of 305 studies with 361 243 participants were included. Most concerned routine care (178 studies) and the general population (27 studies). In factor analyses, both scales reflected a combination of domain-specific factors (cardiopulmonary, fatigue, gastrointestinal, pain) and a general symptom burden factor. The pooled PHQ-15 α was 0.81 (95% CI, 0.80-0.82), but with low item-total correlations for items concerning menstrual problems, fainting spells, and sexual problems (item-total correlations <0.40), and the SSS-8 α was 0.80 (0.77-0.83). Pooled correlations with other measures of somatic symptom burden were 0.71 (95% CI, 0.64-0.78) for the PHQ-15 and 0.82 (95% CI, 0.72-0.92) for the SSS-8. Reported AUROCs for identification of somatoform disorders ranged from 0.63 (95% CI, 0.50-0.76) to 0.79 (95% CI, 0.73-0.85) for the PHQ-15 and from 0.71 (95% CI, 0.66-0.77) to 0.73 (95% CI, 0.69-0.76) for the SSS-8. The minimal clinically important difference on both scales was 3 points. Test-retest reliability could not be pooled and was inconsistent for the PHQ-15 (PHQ-15: r = 0.65-0.93; ICC, 0.87; SSS-8: r = 0.996, ICC = 0.89). The PHQ-15 showed tentative sensitivity to change (g = 0.32; 95% CI, 0.08-0.56), but data for the SSS-8 were lacking.

Conclusions and Relevance In this systematic review and meta-analysis, findings supported use of the PHQ-15 and SSS-8 for the assessment of symptom burden, but users should be aware of the complex, multifactorial structures of these scales. More evidence is needed concerning longitudinal measurement properties.

Open access

 

Related study, Understanding General Somatic Symptom Burden: Insights from a Systematic Review of Factor Analyses Pertaining to [PHQ-15] and [SSS- 8] 2025 Axelsson+

 

At least moderate or high risk of bias for all studies:


Some indication of publication bias:


This might be a useful reference for MCID:

———

I doubt this will stop their use for exactly that.

———

I believe the highlighted sentence above is directly contradicted by the limitations. If most studies have a high risk of bias, they can’t be supportive of anything. They are, at best, inconclusive.

 

Oh wow, did the skull shape caliper scale built around a specific morphology find that the specific morphology it was built to promote as superior find that different morphologies are different and therefore validated as being inferior? Shocker!

The most absurd thing is that unlike those biased questionnaires, measuring skull shapes is an actual objective measurement, although any interpretation remains as invalid as astrology. Measuring something has a precise meaning in science, a meaning that no questionnaire can ever reach. They rate, they don't measure anything. Their scales are not linear, so they can't even be properly called scales, and their construction has zero relevance to the physical world we live in. Scoring is also a fine term, which the authors recognize:

No way, you're telling me that reducing complex multidimensional structures that can't be mapped out to a single digit on a small non-linear and arbitrary 'scale' may not reflect the complex multidimensional nature of that structure? Well, I nevah! Then why pretend with the conclusion that this is any valid?

It's absolutely scandalous that such a large number of studies have been conducted for something this ridiculously pseudoscientific.